REGENCY HOSPITAL OF MERIDIAN
1. Target Overview & Investment Thesis
REGENCY HOSPITAL OF MERIDIAN is a 40-bed community hospital in LAUDERDALE, MS with $11.0M in net patient revenue and a 7.0% operating margin. The hospital serves a payer mix of 57.6% Medicare, 0.0% Medicaid, and 42.4% commercial.
Thesis: Turnaround. Our ML models identify $817K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.0% to 14.4% (+740bps).
| Net Revenue HCRIS | $11.0M |
| Current EBITDA COMPUTED | $776K |
| Operating Margin COMPUTED | 7.0% |
| Occupancy HCRIS | 39.0% |
| Revenue / Bed COMPUTED | $276K |
| Net-to-Gross HCRIS | 12.1% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of 7.0% places it above the state median. Among 66 size-comparable peers (20-80 beds), the median margin is -14.4%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (20-80), prioritizing same-state peers. 66 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| REGENCY HOSPITAL OF MERIDIAN (Target) | MS | 40 | $11.0M | 7.0% |
| KINGS DAUGHTERS MEDICAL CENTER | MS | 22 | $91.5M | -8.4% |
| METHODIST H/C OLIVE BRANCH HOS | MS | 65 | $75.4M | -25.6% |
| NORTH SUNFLOWER COUNTY HOSPITA | MS | 25 | $70.1M | -7.2% |
| MISSISSIPPI METHODIST REHAB CE | MS | 31 | $68.1M | -0.5% |
| UMMC-GRENADA | MS | 49 | $63.7M | 7.1% |
| NESHOBA COUNTY GENERAL HOSPITA | MS | 38 | $47.6M | -19.7% |
| ALLIANCE HEALTH CENTER | MS | 79 | $46.1M | 32.5% |
| MONROE REGIONAL HOSPITAL | MS | 25 | $45.6M | 0.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $817K (740bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $232K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $221K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $221K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $134K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +9bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $776K |
| + RCM Uplift | +$817K |
| Pro Forma EBITDA | $1.6M |
| Current Margin | 7.0% |
| Pro Forma Margin | 14.4% |
| WC Released (1x) | $423K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $1.2M | $13.3M | 11.13x | 61.9% |
| Base (11x exit) | 10.0x | 11.0x | $1.2M | $15.0M | 12.57x | 65.9% |
| Bull Case | 9.0x | 11.0x | $1.1M | $18.1M | 16.84x | 75.9% |
| Bull (12x exit) | 9.0x | 12.0x | $1.1M | $20.0M | 18.66x | 79.5% |
| Bear Case | 11.0x | 10.0x | $1.3M | $8.8M | 6.71x | 46.4% |
| Bear (11x exit) | 11.0x | 11.0x | $1.3M | $10.1M | 7.71x | 50.4% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Heavy Medicare dependence | Medicare comprises 57.6% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 66 hospitals with 20-80 beds
- Same-state prioritization (n=67)
- Comp margins: P25=-25.4% / P50=-14.4% / P75=-2.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.